Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 65Observational 3

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Acute 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 405Surgical Procedures, Operative 151Interviews as Topic 131Radiotherapy 130Observation 122Drug Therapy 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 58Watchful Waiting 51Immunotherapy 51Bevacizumab 49Positron Emission Tomography Computed Tomography 46Ultrasonography 44Liquid Biopsy 41Hematologic Tests 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Observational × plerixafor × Clear all
NCT03406091 2024-02-20

Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Fondazione EMN Italy Onlus

Completed
300 enrolled
Plasma cell

Multiple Myeloma

NCT01141543 2014-07-18

Feasibility and Efficiency Study of Leukemic Cell Mobilization With Plerixafor Injection

University Health Network, Toronto

Completed
12 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01700608 2012-10-04

Prospective Observational Study on Plerixafor After Chemotherapy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Completed
27 enrolled
LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡